Question · asked by 1 review
Calcitonin (salmon calcitonin nasal spray 200 IU/day) vs placebo: Adverse events
- Population
- Patients with histologically confirmed CGCG in one or both jaws and normal serum calcium and parathyroid hormone (PTH) levels
- Intervention
- Calcitonin (salmon calcitonin nasal spray 200 IU/day)
- Comparison
- placebo
- Outcome
- Adverse events
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Calcitonin (salmon calcitonin nasal spray 200 IU/day) vs Placebo Adverse events · Patients with histologically confirmed CGCG in one or both jaws and normal serum calcium and parathyroid hormone (PTH)… Interventions for central giant cell granuloma (CGCG) of the jaws (2009) · Cochrane All outcomes | Adverse events were not described separately for each group. Trialists reported that adverse events were in most patients minimal and consisted of nausea, flushes and some dizziness. One patient had diarrhoea which… | 1 study · 14 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for central giant cell granuloma (CGCG) of the jaws 2009 · Cochrane All outcomes | 2009-07 | Not listed | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.